多糖辅助剂作为先天性免疫培训剂:为合成疫苗设计提供模式识别受体 (PRR) 激活和代谢重编程的桥梁
Jeong Hyun Moon1, May Thazin Phoo2, Yubin Kim1
1Department of Biological Sciences and Bioengineering, Inha University/Industry-Academia, Interactive R&E Center for Bioprocess Innovation, Inha University, Incheon, 22212, Republic of Korea.
多糖可以训练天生的免疫系统,为疫苗开发提供了新的可能性. 本综述探讨了它们作为辅助剂的作用,通过各种机制增强免疫反应.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 生物材料科学 生物材料科学
背景情况:
- 训练有素的免疫描述了先天的免疫记忆,扩大了对免疫反应的理解.
- 多糖类作为病原体关联的分子模式 (PAMPs),激活模式识别受体 (PRRs).
- 微生物免疫疗法,从科利毒素开始,已经发展到利用多糖.
研究的目的:
- 审查微生物免疫疗法的演变和多糖类作为疫苗辅助剂的使用.
- 讨论多糖类诱导训练免疫和适应性反应的机制.
- 突出基于多糖的平台在合成疫苗增强方面的潜力.
主要方法:
- 关于微生物免疫疗法的历史文献综述和有关多糖的当前研究.
- 对多糖机制的分析:PRR参与,代谢/表观遗传重编程.
- 评估多糖与生物障碍,抗原处理和淋巴结贩运的相互作用.
主要成果:
- 多糖激活PRRs,导致免疫调节效应和先天免疫训练.
- 机制包括代谢和表观遗传重编程,支持先天性和适应性免疫.
- 特定的多糖类如β-glucan,mannan和chitosan显示出作为疫苗辅助剂的希望.
结论:
- 多糖为疫苗辅助剂设计提供了一个合理的方法,利用训练有素的免疫力.
- 它们的物质特性和免疫功能可以提高疫苗的有效性和范围.
- 基于多糖的平台代表了合成疫苗开发的重大进步.
更多相关视频
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
相关概念视频
Vaccinations
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Microorganisms in Medicine and Therapeutics
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Biosynthesis of Polysaccharides
